Main Business

Zhongheng (Nanning) Biopharmaceutical Industry Base (Phase I) Project

2024-08-23| 轻工南宁| 0 Views

●  Capacity: 200 million bottles/year of Xueshuantong (freeze-dried) for traditional Chinese medicine injection, 4 billion tablets, 600 million capsules, 160 million cans of Guilinggao, etc

●  Owner: Zhongheng (Nanning) Investment Co., Ltd

●  Construction site: Nanning City, Guangxi

●  Project OverviewThe total land area of the project is 1030 mu, and it is planned to be constructed in three phases. The first phase of the project includes a traditional Chinese medicine production project, a research and development center, and a packaging material project;  The second phase of the project mainly involves chemical drug projects;  The third phase of the project is a biopharmaceutical project.  It is a modern biopharmaceutical production base that integrates the pharmaceutical industry, chemical pharmaceutical industry, biopharmaceutical industry, health food industry, scientific research base, and pharmaceutical packaging materials - glass bottles.  One of the largest traditional Chinese medicine injection production bases for cardiovascular and cerebrovascular diseases in China. 


中恒(南宁)生物制药产业基地(一期)项目


top